These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 34660335)

  • 1. Interactions Between Pathogenic
    Syed I; Wooten RM
    Front Cell Infect Microbiol; 2021; 11():701362. PubMed ID: 34660335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron Acquisition Mechanisms and Their Role in the Virulence of
    Butt AT; Thomas MS
    Front Cell Infect Microbiol; 2017; 7():460. PubMed ID: 29164069
    [No Abstract]   [Full Text] [Related]  

  • 3. Current Advances in
    Wang G; Zarodkiewicz P; Valvano MA
    Cells; 2020 Dec; 9(12):. PubMed ID: 33322641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The art of persistence-the secrets to Burkholderia chronic infections.
    Lewis ER; Torres AG
    Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27440810
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Badten AJ; Torres AG
    Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543947
    [No Abstract]   [Full Text] [Related]  

  • 6. Melioidosis and glanders modulation of the innate immune system: barriers to current and future vaccine approaches.
    Aschenbroich SA; Lafontaine ER; Hogan RJ
    Expert Rev Vaccines; 2016 Sep; 15(9):1163-81. PubMed ID: 27010618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic resistance in Burkholderia species.
    Rhodes KA; Schweizer HP
    Drug Resist Updat; 2016 Sep; 28():82-90. PubMed ID: 27620956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Burkholderia mallei and pseudomallei vaccines.
    Silva EB; Dow SW
    Front Cell Infect Microbiol; 2013; 3():10. PubMed ID: 23508691
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Papp-Wallace KM; Shapiro AB; Becka SA; Zeiser ET; LiPuma JJ; Lane DJ; Panchal RG; Mueller JP; O'Donnell JP; Miller AA
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Burkholderia mallei and Burkholderia pseudomallei. Study of immuno- and pathogenesis of glanders and melioidosis. Heterologous vaccines].
    Manzeniuk IN; Galina EA; Dorokhin VV; Kalachev IIa; Borzenkov VN; Svetoch EA
    Antibiot Khimioter; 1999; 44(6):21-6. PubMed ID: 10422574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.
    Moustafa DA; Scarff JM; Garcia PP; Cassidy SK; DiGiandomenico A; Waag DM; Inzana TJ; Goldberg JB
    PLoS One; 2015; 10(7):e0132032. PubMed ID: 26148026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis.
    Musson JA; Reynolds CJ; Rinchai D; Nithichanon A; Khaenam P; Favry E; Spink N; Chu KK; De Soyza A; Bancroft GJ; Lertmemongkolchai G; Maillere B; Boyton RJ; Altmann DM; Robinson JH
    J Immunol; 2014 Dec; 193(12):6041-9. PubMed ID: 25392525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice.
    Lafontaine ER; Zimmerman SM; Shaffer TL; Michel F; Gao X; Hogan RJ
    PLoS One; 2013; 8(10):e76804. PubMed ID: 24098563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging role of biologics for the treatment of melioidosis and glanders.
    Tapia D; Sanchez-Villamil JI; Torres AG
    Expert Opin Biol Ther; 2019 Dec; 19(12):1319-1332. PubMed ID: 31590578
    [No Abstract]   [Full Text] [Related]  

  • 15. The Madagascar hissing cockroach as a novel surrogate host for Burkholderia pseudomallei, B. mallei and B. thailandensis.
    Fisher NA; Ribot WJ; Applefeld W; DeShazer D
    BMC Microbiol; 2012 Jun; 12():117. PubMed ID: 22892068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burkholderia mallei and Burkholderia pseudomallei: the causative micro-organisms of glanders and melioidosis.
    Gilad J
    Recent Pat Antiinfect Drug Discov; 2007 Nov; 2(3):233-41. PubMed ID: 18221181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DBSecSys 2.0: a database of Burkholderia mallei and Burkholderia pseudomallei secretion systems.
    Memišević V; Kumar K; Zavaljevski N; DeShazer D; Wallqvist A; Reifman J
    BMC Bioinformatics; 2016 Sep; 17():387. PubMed ID: 27650316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polysaccharides from Burkholderia species as targets for vaccine development, immunomodulation and chemical synthesis.
    Cloutier M; Muru K; Ravicoularamin G; Gauthier C
    Nat Prod Rep; 2018 Dec; 35(12):1251-1293. PubMed ID: 30023998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Virulence by Two-Component Systems in Pathogenic
    Schaefers MM
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32284365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting molecular virulence determinants in Burkholderia to develop vaccine antigens.
    Casey WT; McClean S
    Curr Med Chem; 2015; 22(14):1719-33. PubMed ID: 25850766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.